Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe active lupus, a retrospective study shows.

Diagnosing a complex disease such as lupus will often take several months, and two or three doctor appointments, as you continue to track your symptoms, and your doctor continues to monitor your lab ...

There’s no single test for lupus. If your doctor thinks you might have lupus, they’ll ask you questions about your symptoms and do a few different lab tests to find a diagnosis . Most people with ...

Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other ...

Lupus is an autoimmune condition that can cause pain, problems in multiple organs and systems of the body, inflammation, and complications that range from minor to life threatening. The body’s ...

Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

"Equally exciting is the discovery that this lupus antibody delivers genes to cells ... The researchers confirmed in lab studies that the antibody did not work in tissue that lacked functional ...

Laboratory findings on admission to hospital ... Treatment with high-dose steroids controlled the lupus activity both clinically and serologically. C3 complement level increased to 1.26 g/l ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...

Get Instant Summarized Text (Gist) A lupus-related antibody has been found to enhance immune responses against certain tumors by entering "cold" tumors and activating immune reactions. This ...